Northwire Canada EditionThursday, July 16, 2026
Sign inSubscribe
Northwire
⌕
CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6%
Production / Operations

Telescope Innovations Plans Expansion of DirectInject-LC(TM) Technology Ecosystem to Fuel the Physical AI Revolution

By The Northwire Desk — AI Analysis Jan 20, 2026 · 08:03 TELI · 0.43 Telescope Innovations Corp.
TELI · Price

Executive Summary

  • Telescope Innovations announced its 2026 technology development pipeline, adding two new analytical platforms—DirectInject‑IC™ (Ion Chromatography) and DirectInject‑ICP™ (Inductively Coupled Plasma)—to complement its existing DirectInject‑LC™ system.
  • The new platforms are intended to enable real‑time, autonomous monitoring for industrial applications such as hydrometallurgy, lithium extraction, and energy/battery material processing.
  • Deployment and testing of the DirectInject‑IC™ and DirectInject‑ICP™ versions are targeted for the second half of 2026, expanding Telescope’s addressable market in minerals and inorganic chemistry sectors.

Key Details

  • DirectInject‑IC™ – integrates ion chromatography with the DirectInject platform to provide quantitative analysis of inorganic species; aimed at process monitoring and feedback control in hydrometallurgy, lithium extraction, etc.
  • DirectInject‑ICP™ – couples inductively coupled plasma spectroscopy with DirectInject for elemental analysis; positioned for energy & battery material applications requiring trace metal detection.
  • Both platforms are part of Telescope’s “Sensor Suite” expansion to support autonomous decision‑making in Self‑Driving Labs (SDLs).
  • Expected timeline: early‑adopter deployment and testing slated for H2 2026.
  • CEO Henry Dubina emphasized that the expansions build on the commercial success of DirectInject‑LC™ and aim to capture additional industrial segments related to minerals and inorganic chemistry.

Notable Quotes

“Telescope is not resting on the success of DirectInject‑LC; we are building on that momentum to provide the full analytical ‘eyes’ required for the automation age.” – Henry Dubina, CEO

Materiality Assessment: Non‑Material – Positive (forward‑looking product roadmap with no immediate financial impact).

Read the original news release →

More from Telescope Innovations Corp.

Jun 16, 2026 · 08:01

Triple-digit pre-earnings run meets a wall of cash burn and a quiet going-concern clause.

Earnings Jun 01, 2026 · 08:01

Physical AI Lab Automation & Lithium Processing

Other Apr 13, 2026 · 18:01

Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026

Earnings Mar 16, 2026 · 19:34

Telescope enters development deal with AGI Group

M&A / Property Mar 16, 2026 · 08:02

Telescope Innovations and AGI SDA Launch Technology Development Collaboration

M&A / Property Feb 23, 2026 · 18:19

Telescope installs second self-driving lab at Pfizer

Production / Operations